Empty Capsules Market

Empty Capsules Market by Type (Gelatin (Porcine, Bovine), Non gelatin (HPMC, Pullulan)), Functionality (Delayed release), Application (Antibiotics, Dietary Supplements, Anti- Inflammatory), End User (Pharma, Nutraceuticals) - Global Forecast to 2026

Report Code: PH 2935 Jun, 2021, by marketsandmarkets.com

[216 Pages Report] The global empty capsules market is projected to reach USD 3.7 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 7.2% during the forecast period. The overall growth of the empty capsules market is largely driven by the growing adoption of capsule formulations among the growing geriatric population, the growth of the pharmaceutical market, increasing R&D activities & clinical trial studies, and advancements in capsule delivery technologies. Emerging markets, with their low manufacturing costs, are expected to present significant opportunities for players. Other areas of opportunity are the development of halal gelatin and vegetarian capsules.

Empty Capsules Market

To know about the assumptions considered for the study, Request for Free Sample Report

Covid-19 Impact On The Global Empty Capsules Market

A mix of established pharmaceutical companies, as well as small startups have stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus. Vaccine-related research activities in pharmaceutical and biotechnology companies, research centers, and academic research institutes are considered essential and have been largely unaffected in operations and output. Due to the increase in research activities, the availability of funding for research is expected to grow.

In 2020, the COVID-19 pandemic impacted this market negatively due to supply chain disruptions and the imposition of government regulations on production units. According to connect2india, the export of COVID-19 capsules declined by 33.0% in 2020 (as compared to 2019). However, overall, the pandemic is expected to positively impact the growth of the empty capsules market in the coming years.

The impact of COVID-19 on the empty capsules market is not as significant as that on the overall pharmaceutical industry. Increasing demand for pharmaceuticals and nutraceuticals. The demand for nutraceuticals such as multivitamins and dietary supplements has increased due to the COVID-19 pandemic. Considering safety issues, various pharmaceutical companies are developing COVID-19 vaccines and delivering them through capsules. For instance, Vaxart, Inc. has developed VXA-CoV2-1, an oral COVID-19 tablet vaccine candidate to prevent COVID-19. The candidate is currently under Phase 1 clinical trial and is expected to launch by the end of 2021.

EMPTY CAPSULES: MARKET DYNAMICS

Driver: Increasing demand for nutraceuticals

According to MarketsandMarkets, the nutraceutical ingredients market was valued at USD 162.1 billion in 2020 and is projected to reach USD 227.5 billion by 2025, at a CAGR of 7.0% from 2020 to 2025. Nutraceutical products are usually rich in fiber, antioxidants, heart-healthy ingredients, vitamins and minerals, omega-3 fatty acids, vitamin D, calcium, and whole grains.

Over the last few years, the demand for nutraceuticals has been on the rise due to the growing prevalence of non-communicable diseases such as cancer, diabetes, heart ailments, and lung disorders. Also, during the COVID-19 pandemic, personal health has gained prominence in a large part of the global population. This trend has positioned the nutraceutical industry for further expansion and success in the coming years. This is a positive indicator of market growth as most nutraceuticals are marketed in the capsule form.

Opportunity: Expansion of capsule production in emerging countries

The traditionally lucrative pharmaceuticals market is becoming challenging from a growth perspective due to the diminishing drug pipeline, government-induced pressure to reduce costs and regulations on innovative products. This is encouraging pharmaceutical manufacturers to move their manufacturing bases closer to high-growth emerging markets. Through this, manufacturers can take advantage of low-cost manufacturing along with several financial benefits in terms of attractive tax rates and lenient regulatory guidelines for manufacturing.

A number of major pharmaceutical manufacturers are either planning capacity expansions of their existing plants in emerging countries or setting up new manufacturing plants in emerging markets such as China and India. These investments are aiding the growth of pharmaceutical production, in turn, increasing the demand for empty capsules. Some of the recent expansions in this industry include:

  • In February 2021, Qualicaps Europe S.A.U expanded its presence in the South Asia region. In addition to two production sites based in Europe, the company has capsule manufacturing experts located in the EMEA and South Asia.
  • In October 2020, Lonza invested USD 93 million (CHF 85 million) in its Capsules and Health Ingredients (CHI) Division, a dosage form delivery partner to the biopharma and health nutrition industry. The investment has been made to expand its overall production capacity of capsules within CHI's Capsugel portfolio by 30 billion capsules annually while maintaining the high-quality standards with Lonza's Sigma Series. The investment is expected to increase its capsule production capacity by 15.0%. Lonza's newest investment will be released to eight sites, including Bornem, Belgium; Colmar, France; Greenwood, South Carolina; Haryana, India; Jakarta, Indonesia; Puebla, Mexico; Sagamihara, Japan; and Suzhou, China.

Challenges: Rising prices and lower availability of raw materials in the gelatin industry

Globally, the demand for gelatin and its raw materials has witnessed a significant increase over the entire application spectrum—the pharmaceutical industry, in which the demand for capsules for pharmaceutical production has registered a vast increase, and the food processing, nutraceutical, leather, cosmetic, dying & tanning, and paper production industries. The use of gelatin in food preparations has increased six-fold in the last decade. Similar trends have been observed in the nutraceutical and cosmetic industry, where gelatin is used for the production of dietary supplement capsules, lotions, shampoos, hair sprays, and creams. On the other hand, the leather, tanning, and paper production industries use pigskin and bovine skin for the production of various commercial goods.

The increase in demand has boosted the prices of these ingredients. In the last five years, the gelatin manufacturing industry has faced challenges due to the lower availability of raw materials—bovine hide and bones and pigskin. Raw material costs constitute almost 50–55% of the total costs in the gelatin industry. According to a report by Nitta Gelatin (India), the gelatin industry consumes around 18,000 tons of crushed bones per month in India. However, availability came down to 15,000 tons in the earlier months of 2017. The annual gelatin production is expected to come down to 15,000 tons from 20,000 tons in 2018, due to the non-availability of bones owing to the ban imposed by the government on the slaughter of cattle.

The outbreak of bovine and swine diseases has resulted in regulatory restrictions and guidelines for bovine and pig farmers, which has increased the cost of farming. Feed prices have also increased. The cumulative effect of these factors and the subsequent price hikes have been passed onto end users such as gelatin manufacturers and thus have increased the overall gelatin prices. The slow declining availability of raw material is, therefore, intensifying the demand for these ingredients in the pharmaceutical industry, thus creating a supply-demand imbalance. Thus, raw material supply has to be considered carefully to meet the demand for raw material and gelatin across all industries.

By type, the gelatin capsules segment accounted for the largest share of the empty capsules market in 2020.

Based on type, the empty capsules market is categorized into gelatin capsules and non-gelatin capsules. In 2020, gelatin capsules accounted for the largest share in the empty capsules market. The various advantages of gelatin capsules, such as rapid drug release, uniform mixing of drugs, and a barrier to atmospheric oxygen (preventing oxidation of drug molecules), make them a preferred choice for manufacturing capsule shells.

By functionality, the immediate-release capsules accounted for the largest share of the empty capsules market in 2020.

Based on functionality, the empty capsules market has been segmented into immediate-release, sustained-release, and delayed-release capsules. In 2020, immediate-release capsules accounted for a major share in the empty capsules market. This is because immediate-release capsules are widely used to manufacture antibiotics, antibacterials, antacids, painkillers, inhalators, cold and cough drug preparations, and dietary supplements.

By therapeutic application, the antibiotic & antibacterial segment accounted for the largest share of the empty capsules market in 2020.

Based on therapeutic applications, the empty capsules market is segmented into antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, antianemic preparations (hematinic), anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, and other therapeutic applications.

By end user, the pharmaceutical industry segment accounted for the largest share of the empty capsules market in 2020.

Based on end users, the empty capsules market is segmented into the pharmaceutical industry, nutraceutical industry, cosmetic industry, and research laboratories. The pharmaceutical industry segment accounted for the largest share in the empty capsules market in 2020. The demand for empty capsules in the pharmaceutical industry is largely driven by the increasing number of drugs launched as capsule formulations and the growing prevalence of diseases for which capsule-based formulations form the primary treatment.

North America accounted for the largest share of the empty capsules market in 2020.

Geographically, the market is dominated by developed countries across North America and Europe, which account for ~65.6% of the global market. North America accounted for the largest share of 37.4% of the global market. The dominance of the North American region can be attributed to the existing presence of major capsule manufacturers with large production capacities, along with the presence of a number of pharmaceutical giants with large production capacities utilizing these capsules. The growing emphasis on superior pharmaceutical products and generics has also led to increased demand for empty capsules. The emerging markets across the Asia Pacific and Latin America are expected to grow at robust CAGRs during the forecast period. With significant growth in pharmaceutical manufacturing in the past few years, China and India have emerged as high-growth markets for empty capsules.

Empty Capsules Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

The market is highly competitive, with a number of players competing for a larger market share. The prominent players in this market are Capsugel (US), ACG Worldwide (India), Qualicaps (US), Suheung Co. Ltd. (Korea), CapsCanada Corporation (Canada), Qingdao Yiqing Medicinal Capsules Co., Ltd. (China), Shanxi Guangsheng Medicinal Capsules Co., Ltd. (China), Healthcaps India Ltd. (India) and among others

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market Size Available for Years

2019–2026

Base Year Considered

2020

Forecast Period

2021–2026

Forecast Units

Value (USD Billion)

Segments Covered

Type, Functionality, Therapeutic Application, End User

Geographies Covered

North America, Europe, APAC, Latin America and Middle East & Africa

Companies Covered

The major market players include as Capsugel (US), ACG Worldwide (India), Qualicaps (US), Suheung Co. Ltd. (Korea), CapsCanada Corporation (Canada), Qingdao Yiqing Medicinal Capsules Co., Ltd. (China), Shanxi Guangsheng Medicinal Capsules Co., Ltd (China), Healthcaps India Ltd. (India) and others (Total 25 companies)

The study categorizes the empty capsules market into the following segments and subsegments:

Type

  • Gelatin Capsules
    • Porcine
    • Bovine
    • Bone Meal
    • Other Gelatin Sources
  • Non-Gelatin Capsules
    • Hydroxypropyl Methylcellulose (HPMC)
    • Pullulan and Starch Material

Functionality

  • Immediate-release Capsules
  • Sustained-release Capsules
  • Delayed-release Capsules

Application

  • Antibiotic & Antibacterial Drugs
  • Dietary Supplements
  • Antacid & Antiflatulent Preparations
  • Antianemic Preparations
  • Anti-inflammatory Drugs
  • Cardiovascular Therapy Drugs
  • Cough & Cold Drug Preparations
  • Other Therapeutic Applications

End User

  • Pharmaceutical Industry
  • Nutraceutical Industry
  • Cosmetic Industry
  • Research Laboratories

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
  • The Middle East and Africa

Recent Developments

  • In 2021, Nutra’V TiO2 launched a new range of TiO2-free capsules. Available both in gelatin and HPMC and with excellent machinability, this range of capsules offers the best encapsulation solution for ingredient masking.
  • In 2019, ACG acquired Xertecs, Xertecs develops and implements processes, products, and services for pharma companies across the globe. Its acquisition added to ACG’s capabilities.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 21)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 SEGMENTS
           1.3.1 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 26)
    2.1 RESEARCH APPROACH
    2.2 PRIMARIES
    2.3 TOP-DOWN & BOTTOM-UP APPROACHES
    2.4 GROWTH FORECAST ASSUMPTIONS
           2.4.1 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
                    2.4.1.1 Supply-side assessment
                    2.4.1.2 Demand-side assessment
                    2.4.1.3 Insights from primary experts
    2.5 DATA TRIANGULATION APPROACH
           2.5.1 SECONDARY RESEARCH
           2.5.2 PRIMARY RESEARCH
    2.6 ASSUMPTIONS
           2.6.1 COVID-19-SPECIFIC ASSUMPTIONS
    2.7 LIMITATIONS
    2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY (Page No. - 35)

4 PREMIUM INSIGHTS (Page No. - 39)
    4.1 EMPTY CAPSULES MARKET OVERVIEW
    4.2 NORTH AMERICA: EMPTY CAPSULES MARKET SHARE, BY TYPE & COUNTRY (2020)
    4.3 EMPTY CAPSULES MARKET SHARE, BY FUNCTIONALITY (2020)
    4.4 EMPTY CAPSULES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW (Page No. - 42)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 MARKET DRIVERS
           5.2.2 MARKET RESTRAINTS
           5.2.3 MARKET OPPORTUNITIES
           5.2.4 MARKET CHALLENGES
    5.3 RANGES/SCENARIOS
    5.4 IMPACT OF COVID-19 ON THE EMPTY CAPSULES MARKET
           5.4.1 COVID-19 HEALTH ASSESSMENT
           5.4.2 IMPACT ON THE EMPTY CAPSULES MARKET
           5.4.3 IMPACT OF DRIVERS DURING THE COVID-19 PANDEMIC
    5.5 TRENDS/DISRUPTIONS IMPACTING THE BUSINESS OF CUSTOMERS
           5.5.1 REVENUE SHIFT & NEW REVENUE POCKETS FOR EMPTY CAPSULES MANUFACTURERS
    5.6 PRICING ANALYSIS
    5.7 ECOSYSTEM/MARKET MAP
    5.8 VALUE CHAIN ANALYSIS OF THE EMPTY CAPSULES MARKET
    5.9 TECHNOLOGICAL ANALYSIS
           5.9.1 EMPTY CAPSULES
    5.10 PATENT ANALYSIS
    5.11 TRADE ANALYSIS
    5.12 REGULATORY LANDSCAPE
    5.13 PORTER’S FIVE FORCES ANALYSIS
           5.13.1 THREAT OF NEW ENTRANTS
           5.13.2 THREAT OF SUBSTITUTES
           5.13.3 BARGAINING POWER OF SUPPLIERS
           5.13.4 BARGAINING POWER OF BUYERS
           5.13.5 DEGREE OF COMPETITION
    5.14 PHARMACEUTICAL GELATIN MARKET
    5.15 INDUSTRY TRENDS

6 EMPTY CAPSULES MARKET, BY TYPE (Page No. - 67)
    6.1 INTRODUCTION
    6.2 GELATIN CAPSULES
           6.2.1 PORCINE GELATIN
           6.2.2 BOVINE GELATIN
           6.2.3 BONE MEAL
           6.2.4 OTHER GELATIN SOURCES
    6.3 NON-GELATIN CAPSULES
           6.3.1 HYDROXYPROPYL METHYLCELLULOSE
           6.3.2 PULLULAN & STARCH

7 EMPTY CAPSULES MARKET, BY FUNCTIONALITY (Page No. - 79)
    7.1 INTRODUCTION
    7.2 IMMEDIATE-RELEASE CAPSULES
    7.3 SUSTAINED-RELEASE CAPSULES
    7.4 DELAYED-RELEASE CAPSULES

8 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION (Page No. - 84)
    8.1 INTRODUCTION
    8.2 ANTIBIOTIC & ANTIBACTERIAL DRUGS
    8.3 DIETARY SUPPLEMENTS
    8.4 ANTACID & ANTIFLATULENT PREPARATIONS
    8.5 ANTIANEMIC PREPARATIONS
    8.6 ANTI-INFLAMMATORY DRUGS
    8.7 CARDIOVASCULAR THERAPY DRUGS
    8.8 COUGH & COLD DRUGS
    8.9 OTHER THERAPEUTIC APPLICATIONS

9 EMPTY CAPSULES MARKET, BY END USER (Page No. - 93)
    9.1 INTRODUCTION
    9.2 PHARMACEUTICAL INDUSTRY
    9.3 NUTRACEUTICAL INDUSTRY
    9.4 COSMETIC INDUSTRY
    9.5 RESEARCH LABORATORIES

10 EMPTY CAPSULES MARKET, BY REGION (Page No. - 99)
     10.1 INTRODUCTION
     10.2 NORTH AMERICA
             10.2.1 US
             10.2.2 CANADA
     10.3 EUROPE
             10.3.1 GERMANY
             10.3.2 UK
             10.3.3 FRANCE
             10.3.4 ITALY
             10.3.5 SPAIN
             10.3.6 ROE
     10.4 ASIA PACIFIC
             10.4.1 JAPAN
             10.4.2 CHINA
             10.4.3 INDIA
             10.4.4 ROAPAC
     10.5 LATIN AMERICA
     10.6 MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE (Page No. - 148)
     11.1 INTRODUCTION
     11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY MARKET PLAYERS
     11.3 REVENUE ANALYSIS
     11.4 MARKET SHARE ANALYSIS
     11.5 COMPANY EVALUATION QUADRANT
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
     11.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 STARTING BLOCKS
             11.6.3 RESPONSIVE COMPANIES
             11.6.4 DYNAMIC COMPANIES
     11.7 COMPETITIVE BENCHMARKING
     11.8 GROWTH STRATEGIES ADOPTED BY MAJOR AND EMERGING PLAYERS
             11.8.1 EMPTY CAPSULES MARKET: KEY DEALS (JANUARY 2018 TO JUNE 2021)

12 COMPANY PROFILES (Page No. - 161)
     12.1 KEY MARKET PLAYERS
             12.1.1 CAPSUGEL (LONZA GROUP LTD.)
             12.1.2 ACG
             12.1.3 MITSUBISHI CHEMICAL HOLDINGS CORPORATION
             12.1.4 SUHEUNG
             12.1.5 CAPSCANADA CORPORATION
             12.1.6 QINGDAO YIQING MEDICINAL CAPSULES
             12.1.7 SHANXI GUANGSHENG MEDICINAL CAPSULE
             12.1.8 HEALTH CAPS INDIA
             12.1.9 SNAIL PHARMA INDUSTRY
             12.1.10 ROXLOR
             12.1.11 SUNIL HEALTHCARE
             12.1.12 MEDI-CAPS
             12.1.13 NECTAR LIFESCIENCES
             12.1.14 NATURAL CAPSULES
             12.1.15 BRIGHT PHARMA CAPS
     12.2 OTHERS MARKET PLAYERS
             12.2.1 ERAWAT PHARMA LIMITED
             12.2.2 COMED CHEMICALS
             12.2.3 FORTCAPS HEALTHCARE
             12.2.4 SHAOXING ZHONGYA CAPSULE
             12.2.5 FARMACAPSULAS
             12.4.6 SHREE PHARMA CAPS
             12.3.7 LFA MACHINES OXFORD
             12.3.8 SHAOXING KANGKE CAPSULE
             12.3.9 ZHEJIANG YUEXI CAPSULE
             12.3.10 SAVIOUR CAPS

13 APPENDIX (Page No. - 209)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS


LIST OF TABLES(176 Tables)

TABLE 1 EMPTY CAPSULES MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 EMPTY CAPSULES MARKET, PRIMARY RESPONDENTS
TABLE 3 EMPTY CAPSULES MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 AVERAGE PRICE OF EMPTY CAPSULES, BY REGION, 2020
TABLE 5 EMPTY CAPSULES MARKET ECOSYSTEM
TABLE 6 LIST OF A FEW PATENTS IN THE EMPTY CAPSULES MARKET
TABLE 7 EXPORT DATA OF EMPTY CAPSULES FROM INDIA, 2010–2020
TABLE 8 COUNTRY-WISE EXPORT DATA OF EMPTY CAPSULES FROM INDIA, 2010–2020
TABLE 9 INDIA: IMPORT DATA OF EMPTY CAPSULES
TABLE 10 EMPTY CAPSULES MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 11 GROWTH IN THE NUTRACEUTICAL & COSMETIC INDUSTRIES AND INCREASING COLLABORATIONS AMONG EMPTY CAPSULE MANUFACTURERS ARE THE LEADING TRENDS IN THE MARKET
TABLE 12 EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 13 EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (BILLION UNITS)
TABLE 14 GELATIN CAPSULES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 15 GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION)
TABLE 16 PORCINE GELATIN MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 17 BOVINE GELATIN MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 18 BONE MEAL MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 19 OTHER GELATIN SOURCES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 20 NON-GELATIN CAPSULES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 21 NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 22 MAJOR PRODUCTS IN THE HPMC MARKET
TABLE 23 HYDROXYPROPYL METHYLCELLULOSE MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 24 PULLULAN & STARCH MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 25 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 26 IMMEDIATE-RELEASE CAPSULES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 27 SUSTAINED-RELEASE CAPSULES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 28 DELAYED-RELEASE CAPSULES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 29 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION)
TABLE 30 EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY REGION, 2019–2026 (USD MILLION)
TABLE 31 EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2019–2026 (USD MILLION)
TABLE 32 EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY REGION, 2019–2026 (USD MILLION)
TABLE 33 EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY REGION, 2019–2026 (USD MILLION)
TABLE 34 EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY REGION, 2019–2026 (USD MILLION)
TABLE 35 EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY REGION, 2019–2026 (USD MILLION)
TABLE 36 EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY REGION, 2019–2026 (USD MILLION)
TABLE 37 EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
TABLE 38 EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 39 EMPTY CAPSULES MARKET FOR THE PHARMACEUTICAL INDUSTRY, BY REGION, 2019–2026 (USD MILLION)
TABLE 40 EMPTY CAPSULES MARKET FOR THE NUTRACEUTICAL INDUSTRY, BY REGION, 2019–2026 (USD MILLION)
TABLE 41 EMPTY CAPSULES MARKET FOR THE COSMETIC INDUSTRY, BY REGION, 2019–2026 (USD MILLION)
TABLE 42 EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY REGION, 2019–2026 (USD MILLION)
TABLE 43 EMPTY CAPSULES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 44 EMPTY CAPSULES MARKET, BY REGION, 2019-2026 (BILLION UNITS)
TABLE 45 NORTH AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 46 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 47 NORTH AMERICA: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION)
TABLE 48 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 49 NORTH AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 50 NORTH AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION)
TABLE 51 NORTH AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 52 US: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 53 US: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION)
TABLE 54 US: NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 55 US: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 56 US: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION)
TABLE 57 US: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 58 CANADA: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 59 CANADA: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION)
TABLE 60 CANADA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 61 CANADA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 62 CANADA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION)
TABLE 63 CANADA: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 64 EUROPE: EMPTY CAPSULES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 65 EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 66 EUROPE: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION)
TABLE 67 EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 68 EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 69 EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION)
TABLE 70 EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 71 GERMANY: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 72 GERMANY: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION)
TABLE 73 GERMANY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 74 GERMANY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 75 GERMANY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION)
TABLE 76 GERMANY: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 77 UK: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 78 UK: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION)
TABLE 79 UK: NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 80 UK: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 81 UK: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION)
TABLE 82 UK: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 83 FRANCE: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 84 FRANCE: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION)
TABLE 85 FRANCE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 FRANCE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 87 FRANCE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION)
TABLE 88 FRANCE: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 89 ITALY: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 90 ITALY: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION)
TABLE 91 ITALY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 92 ITALY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 93 ITALY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION)
TABLE 94 ITALY: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 95 SPAIN: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 96 SPAIN: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION)
TABLE 97 SPAIN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 98 SPAIN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 99 SPAIN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION)
TABLE 100 SPAIN: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 101 ROE: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 102 ROE: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION)
TABLE 103 ROE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 104 ROE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 105 ROE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION)
TABLE 106 ROE: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 107 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 108 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 109 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION)
TABLE 110 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 111 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 112 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION)
TABLE 113 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 114 JAPAN: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 115 JAPAN: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION)
TABLE 116 JAPAN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 117 JAPAN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 118 JAPAN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION)
TABLE 119 JAPAN: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 120 CHINA: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 121 CHINA: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION)
TABLE 122 CHINA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 123 CHINA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 124 CHINA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION)
TABLE 125 CHINA: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 126 INDIA: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 127 INDIA: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION)
TABLE 128 INDIA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 129 INDIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 130 INDIA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION)
TABLE 131 INDIA: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 132 ROAPAC: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 133 ROAPAC: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION)
TABLE 134 ROAPAC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 135 ROAPAC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 136 ROAPAC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION)
TABLE 137 ROAPAC: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 138 LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 139 LATIN AMERICA: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION)
TABLE 140 LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 141 LATIN AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 142 LATIN AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION)
TABLE 143 LATTIN AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 144 MEA: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 145 MEA: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION)
TABLE 146 MEA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 147 MEA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 148 MEA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION)
TABLE 149 MEA: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 150 COMPANY INDUSTRY FOOTPRINT (25 COMPANIES)
TABLE 151 COMPANY REGION FOOTPRINT (25 COMPANIES)
TABLE 152 COMPANY OFFERING FOOTPRINT (25 COMPANIES)
TABLE 153 CAPSUGEL (LONZA GROUP): BUSINESS OVERVIEW
TABLE 154 ACG: BUSINESS OVERVIEW
TABLE 155 QUALICAPS (MITSUBISHI CHEMICAL HOLDINGS CORPORATION): BUSINESS OVERVIEW
TABLE 156 SUHEUNG: BUSINESS OVERVIEW
TABLE 157 CAPSCANADA CORPORATION: BUSINESS OVERVIEW
TABLE 158 QINGDAO YIQING MEDICINAL CAPSULES: BUSINESS OVERVIEW
TABLE 159 SHANXI GUANGSHENG MEDICINAL CAPSULE: BUSINESS OVERVIEW
TABLE 160 HEALTH CAPS INDIA: BUSINESS OVERVIEW
TABLE 161 SNAIL PHARMA INDUSTRY: BUSINESS OVERVIEW
TABLE 162 ROXLOR: BUSINESS OVERVIEW
TABLE 163 SUNIL HEALTHCARE: BUSINESS OVERVIEW
TABLE 164 MEDI-CAPS: BUSINESS OVERVIEW
TABLE 165 NECTAR LIFESCIENCES: BUSINESS OVERVIEW
TABLE 166 NATURAL CAPSULES: BUSINESS OVERVIEW
TABLE 167 BRIGHT PHARMA CAPS: BUSINESS OVERVIEW
TABLE 168 ERAWAT PHARMA LIMITED: BUSINESS OVERVIEW
TABLE 169 COMED CHEMICALS: BUSINESS OVERVIEW
TABLE 170 FORTCAPS HEALTHCARE: BUSINESS OVERVIEW
TABLE 171 SHAOXING ZHONGYA CAPSULE: BUSINESS OVERVIEW
TABLE 172 FARMACAPSULAS: BUSINESS OVERVIEW
TABLE 173 SHREE PHARMA CAPS: COMPANY OVERVIEW
TABLE 174 LFA MACHINES OXFORD: COMPANY OVERVIEW
TABLE 175 SAVIOUR CAPS PVT. LIMITED: COMPANY OVERVIEW
TABLE 176 ZHEJIANG YUEXI CAPSULE: COMPANY OVERVIEW
 
 
LIST OF FIGURES(40 Figures)
 
FIGURE 1 EMPTY CAPSULES MARKET SEGMENTATION
FIGURE 2 EMPTY CAPSULES MARKET, BY REGION
FIGURE 3 RESEARCH DESIGN
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 5 REVENUE-BASED MARKET SIZE ESTIMATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 EMPTY CAPSULES MARKET SHARE, BY TYPE, 2020 VS. 2026
FIGURE 8 EMPTY CAPSULES MARKET SHARE, BY FUNCTIONALITY, 2020
FIGURE 9 EMPTY CAPSULES MARKET SHARE, BY THERAPEUTIC APPLICATION, 2021 VS. 2026
FIGURE 10 EMPTY CAPSULES MARKET SHARE, BY END USER, 2020
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE EMPTY CAPSULES MARKET
FIGURE 12 INCREASING DEMAND FOR NUTRACEUTICALS TO DRIVE MARKET GROWTH
FIGURE 13 GELATIN CAPSULES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN EMPTY CAPSULES MARKET IN 2020
FIGURE 14 IMMEDIATE-RELEASE CAPSULES HELD THE DOMINANT SHARE OF THE MARKET IN 2020
FIGURE 15 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE EMPTY CAPSULES MARKET FROM 2021 TO 2026
FIGURE 16 PROJECTED GROWTH IN THE POPULATION AGED 60 AND OLDER, 2015 VS. 2030 VS. 2050
FIGURE 17 PROJECTED GROWTH IN THE POPULATION AGED 80 AND OLDER, 2015 VS. 2030 VS. 2050
FIGURE 18 DEPENDING ON HOW THE UNCERTAINTIES UNFOLD, WE SEE A SPECTRUM OF SCENARIOS FOR THE EMPTY CAPSULES MARKET - 2020
FIGURE 19 COVID-19 GLOBAL PROPAGATION
FIGURE 20 COVID-19 PROPAGATION: SELECT COUNTRIES
FIGURE 21 EMPTY CAPSULES MARKET–WITH VS. WITHOUT COVID-19 SCENARIO, 2020 (USD MILLION)
FIGURE 22 REVENUE SHIFT FOR THE EMPTY CAPSULES MARKET
FIGURE 23 NUMBER OF PATENTS GRANTED FOR EMPTY CAPSULES, 2010–2020
FIGURE 24 REGIONAL ANALYSIS OF PATENTS GRANTED FOR EMPTY CAPSULES, 2020
FIGURE 25 TOP PORTS IN INDIA FOR THE EXPORT OF EMPTY CAPSULES
FIGURE 26 YEAR-WISE ANALYSIS OF EMPTY CAPSULE IMPORTS TO INDIA, 2010–2020
FIGURE 27 EMPTY CAPSULES MARKET: REGIONAL SNAPSHOT (2020 VS 2026)
FIGURE 28 EMPTY CAPSULES MARKET: NORTH AMERICA SNAPSHOT
FIGURE 29 EMPTY CAPSULES MARKET: ASIA PACIFIC SNAPSHOT
FIGURE 30 REVENUE ANALYSIS FOR KEY COMPANIES OVER THE PAST THREE YEARS
FIGURE 31 EMPTY CAPSULES MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2020)
FIGURE 32 EMPTY CAPSULES MARKET: COMPANY EVALUATION QUADRANT, 2020
FIGURE 33 EMPTY CAPSULES MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
FIGURE 34 COMPANY PRODUCT FOOTPRINT (25 COMPANIES)
FIGURE 35 LONZA GROUP LTD.: COMPANY SNAPSHOT (2020)
FIGURE 36 MITSUBISHI CHEMICAL HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020)
FIGURE 37 SUNIL HEALTHCARE: COMPANY SNAPSHOT (2020)
FIGURE 38 MEDI-CAPS: COMPANY SNAPSHOT (2020)
FIGURE 39 NECTAR LIFESCIENCES: COMPANY SNAPSHOT (2020)
FIGURE 40 NATURAL CAPSULES: COMPANY SNAPSHOT (2020)

In the primary research process, various sources from both supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, product and innovation directors, and related key executives from various key companies and organizations operating in the empty capsules market. The primary sources from the demand side include industry experts from drug manufacturing companies and contract manufacturing organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

Secondary Data

This research study involved the use of widespread secondary sources; directories; databases such as D&B, Bloomberg Business, and Factiva; white papers; annual reports; and Companies’ House documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global empty capsules market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, key developments related to the market, and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

The various secondary sources referred for this study include the European Federation of Pharmaceutical Industries and Associations (EFPIA), Central Drugs Standard Control Organization (CDSCO), Drugs Technical Advisory Board (DTAB), Pharmaceutical Research and Manufacturers of America (PhRMA), Indian Pharmaceutical Association (IPA), Indian Drug Manufacturers’ Association, Generics and Biosimilars Initiative (GaBI), PharmaTimes, World Journal of Pharmaceutical Sciences, World Health Organization (WHO), P-MEC News, Expert Interviews, India2Connect, Zauba, CDC, Company Websites, Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, and MarketsandMarkets Analysis.

Primary Dada

Extensive primary research was conducted after acquiring basic knowledge about the global empty capsules market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as personnel from pharmaceutical & biotechnology companies and academic & research institutes as well as purchase managers in healthcare provider organizations) and the supply side (such as C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, service providers, and channel partners, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 50% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

Breakdown of primary sources

Empty Capsules Manufactures

Demand Side

Capsugel

National Chemical Laboratory

ACG Worldwide

Institute of Chemical Technology

Suheung Co., Ltd.

 

Bright Pharma Caps Inc.

 

Sunil Healthcare Limited

 

Empty Capsules Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Data Triangulation

To complete the overall market engineering process and to arrive at the exact statistics for all the segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable

Report Objectives

  • To define, describe, segment, and forecast the empty capsules market on the basis of type, functionality, research application and end user.
  • To provide detailed information about the factors influencing market growth, such as drivers, restraints, opportunities, and challenges
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall empty capsules market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments concerning five main regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), and the Middle East & Africa (MEA)
  • To strategically profile the key players in the global empty capsules market and comprehensively analyze their core competencies2 and market rankings
  • To track and analyze competitive developments, such as product launches, acquisitions, collaborations, expansions, and partnerships in the empty capsules market

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analsis

  • Further breakdown of the European empty capsules market into countries from the Rest of Europe segment.
  • Further breakdown of the Asia Pacific empty capsules market into countries from the Rest of the APAC segment.
  • Further breakdown of Latin America and the Middle East & Africa empty capsules market into countries.

Company Information

Detailed analysis and profiling of additional market players (up to 5) inclusive of:

  • Business Overview
  • Financial Information
  • Product Offered
  • Developments (Last three years)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Empty Capsules Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Empty Capsules Market

Request For Special Pricing
Report Code
PH 2935
Published ON
Jun, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Empty Capsules Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved